Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Anapen Junior 150mcg Solution for Injection in Prefilled Syringe – PA22580/001/001
- Gaviscon Oral Suspension – PA0979/015/001
- Hydromorphone 20mg/ml Solution for Injection/Infusion – PA0549/030/001
- Levofloxacin 250mg Tablet – PA1347/048/001
- Melfen 200mg Film Coated Tablet- PA0126/012/001
- Nexium Control 20mg Tablet – EU/1/13/860/001-002
- Quinine Sulphate 300mg Tablet – PA1986/052/001
- Ultiva 1mg Powder for Concentrate for solution for Infusion – PA1691/032/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Flucloxacillin 2000mg Powder for Solution for Injection/Infusion – PA1862/003/004
- Isoptin 40mg Film Coated Tablet – PA2010/003/001
- Sildenafil 50mg Film Coated Tablet – PA0126/199/002
- Telmisartan 20mg Film Coated Tablet – PA0126/228/001
- Zacin 0.025% Cream – PA0827/008/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.